Skip to main content
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
3.350
+0.200 (6.35%)
At close: Dec 20, 2024, 4:00 PM
3.390
+0.040 (1.19%)
After-hours: Dec 20, 2024, 7:41 PM EST

aTyr Pharma Revenue

aTyr Pharma had revenue of $235.00K in the twelve months ending September 30, 2024, down -97.81% year-over-year. In the year 2023, aTyr Pharma had annual revenue of $353.00K, down -96.60%.

Revenue (ttm)
$235.00K
Revenue Growth
-97.81%
P/S Ratio
n/a
Revenue / Employee
$3,983
Employees
59
Market Cap
281.21M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023353.00K-10.03M-96.60%
Dec 31, 202210.39M--
Dec 31, 2021---
Dec 31, 202010.46M10.03M2,377.49%
Dec 31, 2019422.00K--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accolade 441.03M
Procaps Group 414.10M
Canopy Growth 207.63M
Amylyx Pharmaceuticals 196.49M
Vanda Pharmaceuticals 190.86M
C4 Therapeutics 33.67M
Foghorn Therapeutics 25.52M
Revenue Rankings

ATYR News

More News